Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
54.65
-0.29 (-0.53%)
At close: Jan 23, 2026, 4:00 PM EST
54.55
-0.10 (-0.18%)
After-hours: Jan 23, 2026, 7:56 PM EST
BMY Employees
Bristol-Myers Squibb Company had 34,100 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
34,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,408,622
Profits / Employee
$177,097
Market Cap
111.25B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 34,100 | 0 | - |
| Dec 31, 2023 | 34,100 | -200 | -0.58% |
| Dec 31, 2022 | 34,300 | 2,100 | 6.52% |
| Dec 31, 2021 | 32,200 | 1,950 | 6.45% |
| Dec 31, 2020 | 30,250 | 250 | 0.83% |
| Dec 31, 2019 | 30,000 | 6,700 | 28.76% |
| Dec 31, 2018 | 23,300 | -400 | -1.69% |
| Dec 31, 2017 | 23,700 | -1,300 | -5.20% |
| Dec 31, 2016 | 25,000 | 0 | - |
| Dec 31, 2015 | 25,000 | 0 | - |
| Dec 31, 2014 | 25,000 | -3,000 | -10.71% |
| Dec 31, 2013 | 28,000 | 0 | - |
| Dec 31, 2012 | 28,000 | 1,000 | 3.70% |
| Dec 31, 2011 | 27,000 | 0 | - |
| Dec 31, 2010 | 27,000 | -1,000 | -3.57% |
| Dec 31, 2009 | 28,000 | -7,000 | -20.00% |
| Dec 31, 2008 | 35,000 | -7,000 | -16.67% |
| Dec 31, 2007 | 42,000 | -1,000 | -2.33% |
| Dec 31, 2006 | 43,000 | 0 | - |
| Dec 31, 2005 | 43,000 | 0 | - |
| Dec 31, 2004 | 43,000 | -1,000 | -2.27% |
| Dec 31, 2003 | 44,000 | 0 | - |
| Dec 31, 2002 | 44,000 | -2,000 | -4.35% |
| Dec 31, 2001 | 46,000 | 2,000 | 4.55% |
| Dec 31, 2000 | 44,000 | -10,500 | -19.27% |
| Dec 31, 1999 | 54,500 | -200 | -0.37% |
| Dec 31, 1998 | 54,700 | 1,100 | 2.05% |
| Dec 31, 1997 | 53,600 | 2,400 | 4.69% |
| Dec 31, 1996 | 51,200 | 2,060 | 4.19% |
| Dec 31, 1995 | 49,140 | 1,440 | 3.02% |
| Dec 31, 1994 | 47,700 | -1,800 | -3.64% |
| Dec 31, 1993 | 49,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 92,900 |
| Sanofi | 82,878 |
| Pfizer | 81,000 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| GSK plc | 68,629 |
| AbbVie | 55,000 |
BMY News
- 10 hours ago - Bristol-Myers Squibb: Solid Tumor Collaboration With Janux And Camzyos Expansion - Seeking Alpha
- 1 day ago - Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million - Benzinga
- 1 day ago - Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug - Reuters
- 1 day ago - Top 10 Dividend Stocks For Uncertain Times - Seeking Alpha
- 3 days ago - Bristol Myers partners with Microsoft for AI-driven lung cancer detection - Reuters
- 3 days ago - Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer - Business Wire
- 8 days ago - 3 Stock Picks Where Technical Indicators Still Say Buy - Barrons
- 11 days ago - Bristol-Myers Squibb Company (BMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha